MedPlus Health Share Price Jumps 11% After Q4 FY26 Net Profit Rises 25% and Revenue Grows 24%

Written by: Kusum KumariUpdated on: 21 May 2026, 5:25 pm IST

MedPlus Health share price surged after strong Q4 results, driven by 25% profit growth, higher revenue and improving operating margins.

MedPlus Health Services share price gained over 11% in intraday trade after the company reported strong financial results for the March quarter (Q4FY26).

The stock touched an intraday high of ₹1,020.35 on the BSE before trimming some gains. Even after the pullback, the stock remained sharply higher while the broader market traded moderately positive.

MedPlus Health Services Q4 FY26 Profit and Revenue Growth

The company reported healthy growth in both profit and revenue during the quarter.

Key Financial Highlights

Net Profit: ₹63.97 crore, up 24.6% YoY
Revenue from Operations: ₹1,864.39 crore, up 23.5% YoY
EBITDA: ₹107.63 crore, compared to ₹80.33 crore last year
EBITDA Margin: Improved to 5.8% from 5.3%

The strong performance was supported by higher sales and improved operational efficiency.

About MedPlus Health

Founded in 2006 by Gangadi Madhukar Reddy, MedPlus is one of India’s largest pharmacy retail chains.

The company operates:

More than 5,000 stores
Across 800+ cities
In 10 Indian states

It employs over 28,000 full-time employees.

Diversified Business Model

Apart from retail pharmacy, MedPlus also operates in:

Wholesale distribution
Manufacturing and contract manufacturing
Private label pharmaceutical and wellness products
Diagnostic centres

The company follows an omni-channel approach, allowing customers to order medicines through physical stores and digital platforms, including WhatsApp.

Conclusion

MedPlus Health’s strong Q4 earnings and margin improvement boosted investor confidence, leading to a sharp rise in the stock price.

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: May 21, 2026, 11:47 AM IST

Kusum Kumari

Kusum Kumari is a Content Writer with 4 years of experience in simplifying financial market concepts. Currently crafting insightful content at Angel One, She specialise in breaking down complex topics into easy-to-understand pieces, blending expertise in market fundamentals and technical analysis.

Know More